Comparison of the effects of losartan, captopril, angiotensin II type 2 receptor agonist compound 21, and MAS receptor agonist AVE 0991 on myocardial ischemia–reperfusion necrosis in rats
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of the effects of losartan, captopril, angiotensin II type 2 receptor agonist compound 21, and MAS receptor agonist AVE 0991 on myocardial ischemia–reperfusion necrosis in rats
Authors
Keywords
-
Journal
FUNDAMENTAL & CLINICAL PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-08-28
DOI
10.1111/fcp.12599
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AVE0991, a Nonpeptide Angiotensin 1-7 Receptor Agonist, Improves Glucose Metabolism in the Skeletal Muscle of Obese Zucker Rats: Possible Involvement of Prooxidant/Antioxidant Mechanisms
- (2020) Viktoria Dobrocsyova et al. Oxidative Medicine and Cellular Longevity
- Mitophagy and mitochondrial integrity in cardiac ischemia-reperfusion injury
- (2019) Mingjie Yang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- AT2R (Angiotensin AT2 Receptor) Agonist, Compound 21, Prevents Abdominal Aortic Aneurysm Progression in the Rat
- (2018) Christoph Lange et al. HYPERTENSION
- The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7)
- (2018) Robson Augusto Souza Santos et al. PHYSIOLOGICAL REVIEWS
- Angiotensin-converting enzyme 2-Angiotensin 1-7/1-9 system: novel promising targets for heart failure treatment
- (2017) Naim Kittana FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Ischemia/Reperfusion Injury following Acute Myocardial Infarction: A Critical Issue for Clinicians and Forensic Pathologists
- (2017) Margherita Neri et al. MEDIATORS OF INFLAMMATION
- AVE 0991 attenuates cardiac hypertrophy through reducing oxidative stress
- (2016) Yuedong Ma et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Angiotensin1-7 protects cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress by preventing ROS-associated mitochondrial dysfunction and activating the Akt signaling pathway
- (2015) Pengjun Zhao et al. ACTA HISTOCHEMICA
- AT2 Receptor Activities and Pathophysiological Implications
- (2015) Luis C. Matavelli et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Activation of Central Angiotensin Type 2 Receptors by Compound 21 Improves Arterial Baroreflex Sensitivity in Rats With Heart Failure
- (2014) J. Gao et al. AMERICAN JOURNAL OF HYPERTENSION
- Protective axis of the renin–angiotensin system in the brain
- (2014) Mariela M. Gironacci et al. CLINICAL SCIENCE
- ACE2: Angiotensin II/Angiotensin-(1–7) Balance in Cardiac and Renal Injury
- (2014) Jasmina Varagic et al. CURRENT HYPERTENSION REPORTS
- Effects of acute angiotensin II on ischemia reperfusion injury following myocardial infarction
- (2014) Sarah Mann et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- The influence of angiotensin-(1–7) Mas receptor agonist (AVE 0991) on mitochondrial proteome in kidneys of apoE knockout mice
- (2013) Maciej Suski et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Angiotensin II Type 1 and Type 2 Receptor-induced Cell Signaling
- (2013) Hiroshi Akazawa et al. CURRENT PHARMACEUTICAL DESIGN
- Myocardial ischemia-reperfusion injury: a neglected therapeutic target
- (2013) Derek J. Hausenloy et al. JOURNAL OF CLINICAL INVESTIGATION
- The nonpeptide ANG-(1–7) mimic AVE 0991 attenuates cardiac remodeling and improves baroreflex sensitivity in renovascular hypertensive rats
- (2013) Thelma Maria Bedeti Cunha et al. LIFE SCIENCES
- Opportunities for Targeting the Angiotensin-Converting Enzyme 2/Angiotensin-(1-7)/Mas Receptor Pathway in Hypertension
- (2012) Rodrigo Araujo Fraga-Silva et al. CURRENT HYPERTENSION REPORTS
- AT2 receptors: beneficial counter-regulatory role in cardiovascular and renal function
- (2012) Shetal H. Padia et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Effects of captopril and angiotensin II receptor blockers (AT1, AT2) on myocardial ischemia–reperfusion induced infarct size
- (2011) Hakan Parlakpinar et al. CYTOKINE
- Angiotensin Type 2 Receptor Agonist Compound 21 Reduces Vascular Injury and Myocardial Fibrosis in Stroke-Prone Spontaneously Hypertensive Rats
- (2011) Asia Rehman et al. HYPERTENSION
- Cell Death Pathways in Acute Ischemia/Reperfusion Injury
- (2011) Roberta A. Gottlieb JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Cardioprotective Effects of a Selective B2 Receptor Agonist of Bradykinin Post-Acute Myocardial Infarct
- (2010) M. Marketou et al. AMERICAN JOURNAL OF HYPERTENSION
- Animal research: Reporting in vivo experiments: The ARRIVE guidelines
- (2010) Carol Kilkenny et al. BRITISH JOURNAL OF PHARMACOLOGY
- Non-peptide AT2-receptor agonists
- (2010) U Muscha Steckelings et al. CURRENT OPINION IN PHARMACOLOGY
- Angiotensin AT 2 Receptor Stimulation Inhibits Early Renal Inflammation in Renovascular Hypertension
- (2010) Luis C. Matavelli et al. HYPERTENSION
- Valsartan preconditioning protects against myocardial ischemia–reperfusion injury through TLR4/NF-κB signaling pathway
- (2009) Jian Yang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Angiotensin II Type 2 Receptor Stimulation
- (2008) Elena Kaschina et al. CIRCULATION
- Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis
- (2008) Robson A. S. Santos et al. EXPERIMENTAL PHYSIOLOGY
- AT2 receptors: Functional relevance in cardiovascular disease
- (2008) Emma S. Jones et al. PHARMACOLOGY & THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started